KAHIRA PHARMACEUTICALS & CHEMICAL INDUSTRIES COMPANY Cairo Pharmaceuticals (CPCI.CA) - Listing Committee Decision
27/02/2022
27/02/2022
Company Name : Cairo Pharmaceuticals
ISIN Code : EGS38391C016
Reuters Code : CPCI.CA
Content :
The Listing Committee held on 24/02/2022 decided to impose EGP 10000 penalty on the company due to the violation of Article 46 of the Listing Rules and Article 64 of the Executive Regulations
ISIN Code : EGS38391C016
Reuters Code : CPCI.CA
Content :
The Listing Committee held on 24/02/2022 decided to impose EGP 10000 penalty on the company due to the violation of Article 46 of the Listing Rules and Article 64 of the Executive Regulations
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Kahira Pharmaceuticals and Chemical Industries Co. published this content on 27 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 February 2022 07:50:05 UTC.
